We are live on ! Find out more
PTHS

Pelthos Therapeutics
PTHS

1 hedge funds and large institutions have $660K invested in Pelthos Therapeutics in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.51% more ownership

Funds ownership: 0% → 0.51% (+0.51%)

Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$882K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$660K +$882K +25,189 New

PTHS Hedge Fund Activity: Q1 2024 in Review

1 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Pelthos Therapeutics (PTHS) for Q1 2024, worth a combined $660K.

Buyers outnumbered sellers: 1 fund opened new PTHS positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $882K.

  • 1 institutional investor held Pelthos Therapeutics (PTHS) as of Q1 2024, up from 0 in Q4 2023.
  • Funds reported $660K of Pelthos Therapeutics stock for Q1 2024.
  • 1 fund opened new Pelthos Therapeutics positions in Q1 2024 and 0 closed out, a net change of +1 holder.
  • The largest Pelthos Therapeutics buyer in Q1 2024 was Anson Funds Management, an estimated $882K added.

Based on aggregated 13F filings for Q1 2024.